{"id":962185,"date":"2026-11-12T20:28:09","date_gmt":"2026-11-12T20:28:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/962185\/"},"modified":"2026-11-12T20:28:09","modified_gmt":"2026-11-12T20:28:09","slug":"inhaled-living-medicine-reduces-drug-resistant-lung-biofilms-in-the-lungs-of-pigs","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/962185\/","title":{"rendered":"Inhaled living medicine reduces drug-resistant lung biofilms in the lungs of pigs"},"content":{"rendered":"<p>A &#8220;living medicine&#8221; has thinned biofilms of antibiotic-resistant Pseudomonas aeruginosa in the lungs of pigs, according to the findings of a study published today in the journal eBioMedicine.<\/p>\n<p>The experimental treatment involves inhaling a genetically modified bacterium designed to target layers of drug-resistant P. aeruginosa that grow on the surfaces of endotracheal tubes used in hospitals.<\/p>\n<p>It&#8217;s the first time the experimental treatment, which has previously only been shown to tackle biofilms in mice, has also worked in pigs, a large animal with lungs that are similar in size, structure and immune response to human lungs.<\/p>\n<p>It&#8217;s also the first time the treatment has been shown to be administrable through a nebulizer, the same type of medical device human patients would use. Breathing in the &#8220;living medicine&#8221; thinned the biofilm inside breathing tubes from 6.08 to 3.67 micrometres, reducing thickness by around 40%.<\/p>\n<p>The treatment involves Mycoplasma pneumoniae, a bacterium which normally causes a mild lung infection but, through genetic engineering, has been repurposed to be harmless for humans. The engineered bacterium was loaded with genes that dissolve sugars holding a biofilm together, as well as toxins that specifically only target Pseudomonas aeruginosa.<\/p>\n<p>&#13;<\/p>\n<p>Our study is part of an emerging field of medicine known as live biotherapeutics. In this case we&#8217;ve taken a bacterium naturally adapted to the lung and reprogrammed it so that it delivers therapeutic molecules instead of causing damage. It&#8217;s a Trojan horse strategy against disease.&#8221;<\/p>\n<p>&#13;<br \/>\n&#13;<\/p>\n<p style=\"text-align: right;\">Dr. Irene Rodr\u00edguez-Arce, senior co-author of the study<\/p>\n<p>&#13;<\/p>\n<p>When examining the lungs afterwards, there were no signs of damage caused by the engineered bacterium. The treatment also showed no measurable effect on the animals&#8217; own airway bacteria, suggesting the living medicine targets Pseudomonas specifically.<\/p>\n<p>The study could one day help patients who cannot breathe for themselves in hospital. They are usually kept alive by passing a tube into the windpipe. Within days, bacteria colonise the inside of that tube and form slimy, protective layer called a biofilm.<\/p>\n<p>Antibiotics given through a drip struggle to penetrate the physical barrier of biofilms, causing recurring infections. In intubated patients, this is a known cause of ventilator-associated pneumonia (VAP). Around 1 in 4 cases are caused by Pseudomonas aeruginosa, which is frequently resistant to several types of antibiotics.<\/p>\n<p>&#8220;<a href=\"https:\/\/www.news-medical.net\/health\/Origins-of-Antibiotic-Resistance.aspx\" class=\"linked-term\" rel=\"nofollow noopener\" target=\"_blank\">Antibiotic resistance<\/a> is a silent pandemic we see affecting intubated patients every day and Pseudomonas aeruginosa is among the hardest infections to clear. Our work represents a different line of attack, and one we badly need,&#8221; says Dr. Antoni Torres, senior co-author of the study.<\/p>\n<p>The authors say their findings support a future first-in-human safety trial. Combining the &#8220;living medicine&#8221; with intravenous antibiotics or making make further tweaks to the molecules that dissolve biofilms could further improve the experimental treatment&#8217;s effectiveness.<\/p>\n<p>&#8220;I am confident that with modifications to the bacterial chassis&#8217; payload, we could completely dissolve the biofilms on the surface of endotracheal tubes and clear P. aureginosa infections entirely,&#8221; explains ICREA Research Professor Luis Serrano, senior co-author of the study. The research team at the CRG are also creating versions of the living medicine that can tackle pulmonary fibrosis and lung cancer.<\/p>\n<p>The study is a collaboration between the Centre for Genomic Regulation (CRG) and Hospital Cl\u00ednic-IDIBAPS, both in Barcelona, with the animal studies carried out at the University of Barcelona. It was led by co first-authors Laia Fern\u00e1ndez-Barat and Ana Motos, with Antoni Torres, Luis Serrano and Irene Rodr\u00edguez-Arce as senior authors. The study is funded by the &#8220;la Caixa&#8221; Foundation and the European Research Council.<\/p>\n<p>Source:<\/p>\n<p><a href=\"https:\/\/www.crg.eu\/en\/news\/living-medicine-tackles-drug-resistant-biofilms-growing-ventilation-tubes\" rel=\"noopener nofollow\" target=\"_blank\">Center for Genomic Regulation<\/a><\/p>\n<p>Journal reference:<\/p>\n<p>Fern\u00e1ndez-Barat, L., et al. (2026). Targeting pseudomonas aeruginosa ventilator-associated pneumonia with a non-antibiotic and biofilm-disrupting live biotherapeutic: Preclinical safety and efficacy study. eBioMedicine.\u00a0DOI:\u00a010.1016\/j.ebiom.2026.106537.\u00a0<a href=\"https:\/\/www.thelancet.com\/journals\/ebiom\/article\/PIIS2352-3964(26)00421-4\/fulltext\" rel=\"noopener nofollow\" target=\"_blank\">https:\/\/www.thelancet.com\/journals\/ebiom\/article\/PIIS2352-3964(26)00421-4\/fulltext<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"A &#8220;living medicine&#8221; has thinned biofilms of antibiotic-resistant Pseudomonas aeruginosa in the lungs of pigs, according to the&hellip;\n","protected":false},"author":2,"featured_media":962186,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[2161,64,63,1592,6635,60586,4078,27538,17763,137,4082,64046,1679,52877,337,530064,163200],"class_list":["post-962185","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-antibiotic","tag-au","tag-australia","tag-bacteria","tag-bacterial","tag-biofilms","tag-breathing","tag-electron","tag-genomic","tag-health","tag-hospital","tag-lungs","tag-medicine","tag-microscope","tag-research","tag-scanning-electron-microscope","tag-ventilator"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/962185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=962185"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/962185\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/962186"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=962185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=962185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=962185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}